Cargando…

Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies

Melanoma is becoming increasingly common worldwide, with high rates of transformation into malignancy compared to other skin lesions. The prognosis of patients with melanoma at an advanced stage is highly unsatisfying despite the development of immunotherapy, target therapy, or combinative therapy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Bo, Miao, Linlin, Mei, Disen, Li, Lingzhi, Zhou, Qiongyan, Dong, Dong, Wang, Songting, Zhu, Xiaoxia, Xu, Suling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236803/ https://www.ncbi.nlm.nih.gov/pubmed/35770115 http://dx.doi.org/10.1155/2022/9633416

Ejemplares similares

A Signature of Genes Featuring FGF11 Revealed Aberrant Fibroblast Activation and Immune Infiltration Properties in Keloid Tissue
por: Yuan, Bo, et al.
Publicado: (2022)

Retracted: Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)

Immune Checkpoint Blockers and Ovarian Cancer
por: Bose, Chinmoy K
Publicado: (2017)

Development of an Immune-Related Gene Signature for Prognosis in Melanoma
por: Zhang, Jia-An, et al.
Publicado: (2021)

Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
por: Lapuente-Santana, Óscar, et al.
Publicado: (2020)

A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
por: Huang, Qian, et al.
Publicado: (2020)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
por: Cao, Wenpeng, et al.
Publicado: (2023)

The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
por: Tomela, Katarzyna, et al.
Publicado: (2020)

Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
por: Hong, Xin, et al.
Publicado: (2018)

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
por: Krebs, Franziska K., et al.
Publicado: (2021)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
por: Wang, Feihu, et al.
Publicado: (2020)

Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs
por: Pantelyushin, Stanislav, et al.
Publicado: (2021)

Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
por: Tsao, Shiu Ying
Publicado: (2022)

Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanoma
por: Hassel, Jessica C.
Publicado: (2021)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma
por: Zeng, Yangyang, et al.
Publicado: (2021)

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects
por: Delahousse, Julia, et al.
Publicado: (2020)

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020)

Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
por: Reschke, Robin, et al.
Publicado: (2021)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
por: Datta, Meenal, et al.
Publicado: (2023)

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma
por: Li, Ai-lan, et al.
Publicado: (2021)

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC
por: Chong, Wei, et al.
Publicado: (2020)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

A Case of Acute Heart Failure due to Immune Checkpoint Blocker Nivolumab
por: Sharma, Munish, et al.
Publicado: (2019)

Prognostic value of lactate dehydrogenase in patients with uveal melanoma treated with immune checkpoint inhibition
por: Liang, Xiaocui, et al.
Publicado: (2023)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

TNF-R1, an immune checkpoint in melanoma?
por: Bertrand, Florie, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors in Melanoma and HIV Infection
por: Marra, Antonio, et al.
Publicado: (2017)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aa6uri4ih7coca939mi8doggqg